Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
CAS NO.341031-54-7
99%(1.00-1000.00)Kilogram
1.More than 8years exporting experience.
2.Lower Price with higher quality
3,Free sample
4,We are sincerely responsible for the "product quality" and "After Service"
Onchem (China) Co.,Ltd is Specialized in APIs, chemical intermediates, herbal extract .
(1) Company Introduction:
Shanghai Upbio Tech Co.,Ltd is a comprehensive manufacturer and an international distribution of chemicals throughout the world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. our products sell
well in Europe, U.S.A., Japan and Korea, Southeast Asia, Taiwan and other country.
(2) Product Detail
Sunitinib malate is our one of key product with high quality. if need,contact me.
Purity:99%
Name: Sunitinib malate
Molecular Formula: C22H27FN4O2·C4H6O5
Molecular Weight: 532.56
CAS Registry Number: 341031-54-7
Appearance: white powder
Item |
Specification |
Results |
Appearance |
Pale yellow to off-white powder |
Conforms |
Identification |
a) IR:IR chromatograph Conforms to the characteristic peak of R.S. |
Conforms |
b) HPLC :The retention time of the major peak in the chromatogram Conforms to the characteristic peak of R.S. |
Conforms |
|
Residue on ignition |
≤ 0.1% |
0.07% |
Loss on drying |
≤1.0% |
0.35% |
Heavy Metals |
≤20 ppm |
Conforms |
Related substance |
||
Single impurity |
≤0.50% |
0.22% |
Total impurities |
≤1.0% |
0.61% |
Assay[HPLC] |
≥99% |
99.5% |
Conclusion |
The results comply with standards of enterprise. |
welcome to inquiry me about all our products, we will provice the
competitive price for u. We are sincerely responsible for the "product quality" and "After Service"
(3) Application
A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic. Astrointestinal stromal tumor,
inhibition of advanced renal cell carcinoma, now clinically proven can also treat non-small cell lung cancer, treatment of
hepatocellular carcinoma.